| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 249.77B | 250.60B | 242.43B | 239.29B | 223.28B | 202.44B |
| Gross Profit | 97.23B | 92.23B | 92.89B | 91.77B | 87.05B | 78.82B |
| EBITDA | 5.62B | 9.11B | 9.72B | 12.97B | 9.25B | 7.68B |
| Net Income | -1.53B | 971.00M | 2.59B | 5.40B | 3.84B | 412.00M |
Balance Sheet | ||||||
| Total Assets | 212.61B | 205.57B | 210.40B | 211.78B | 208.87B | 207.99B |
| Cash, Cash Equivalents and Short-Term Investments | 22.07B | 19.86B | 24.94B | 32.89B | 39.89B | 44.32B |
| Total Debt | 7.26B | 8.40B | 10.96B | 13.05B | 15.59B | 16.04B |
| Total Liabilities | 91.22B | 83.44B | 85.58B | 89.21B | 90.16B | 91.63B |
| Stockholders Equity | 121.00B | 121.72B | 124.45B | 122.36B | 118.67B | 116.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.31B | -2.86B | 1.38B | -2.78B | 20.13B |
| Operating Cash Flow | 0.00 | 12.06B | 4.27B | 7.02B | 2.23B | 25.37B |
| Investing Cash Flow | 0.00 | -9.60B | -8.04B | -5.48B | -5.16B | -2.02B |
| Financing Cash Flow | 0.00 | -7.53B | -4.14B | -7.91B | -2.12B | 8.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥41.00B | 14.03 | ― | 2.19% | 15.14% | 17.01% | |
74 Outperform | ¥263.68B | 11.87 | 10.61% | 1.81% | 6.45% | 12.25% | |
71 Outperform | ¥81.99B | 5.42 | 6.96% | 2.98% | 2.80% | 83.52% | |
64 Neutral | ¥75.40B | 10.29 | ― | 2.11% | 5.55% | 3.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥44.17B | 15.79 | ― | 3.31% | 1.05% | -166.74% | |
43 Neutral | ¥10.40B | 19.13 | ― | 3.08% | 2.51% | -235.45% |